SOPHiA GENETICS (SOPH) CSO Zhenyu Xu Sells 20,000 Shares

What Happened

• Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS (SOPH), sold a total of 20,000 shares in open-market transactions from Aug 19–21, 2026, generating roughly $163,483. The sales broke down as: 10,000 shares on Aug 19 at a weighted average price of $7.94 (≈ $79,427), 4,592 shares on Aug 20 at a weighted average of $8.41 (≈ $38,609), and 5,408 shares on Aug 21 at a weighted average of $8.40 (≈ $45,447). These were sales (not purchases or option exercises).

Key Details

• Transaction dates & prices:
  • 2026-08-19: 10,000 shares sold, weighted avg $7.94 (reported price range $7.90–$8.01). (F2)
  • 2026-08-20: 4,592 shares sold, weighted avg $8.41 (reported price range $8.40–$8.43). (F3)
  • 2026-08-21: 5,408 shares sold, weighted avg $8.40 (reported price range $8.40–$8.42). (F4)
• Total proceeds: ≈ $163,483.
• Footnotes: F1 indicates the transaction(s) were made pursuant to a pre-arranged Rule 10b5-1 trading plan; F2–F4 note weighted-average prices and give the per-trade price ranges and availability of per-price breakdowns on request.
• Shares owned after the transactions: not provided in the excerpt of the filing.
• Filing: Form 4 filed Aug 21, 2026 reporting transactions dated Aug 19–21 — the filing date aligns with the reporting period and is presented as timely in the filing.

Context

• Sales reported under a Rule 10b5-1 plan are typically pre-arranged and can be routine; they do not necessarily signal a change in the insider’s view of the company. For retail investors, purchases usually carry more weight as affirmative insider bets, while planned sales often reflect diversification or pre-set liquidity needs.